This is an opportunity to join a clinical-stage biotechnology company at the forefront of targeted protein degradation and take ownership of the strategic alliances, governance, and program execution that will shape the next generation of oncology and immunology medicines. Reporting into executive leadership, you will operate at the intersection of cutting-edge science, high-value partnerships, and pipeline strategy, leading both external alliances and an expanding portfolio of wholly owned preclinical and early clinical programs.

Key areas of impact:

• Own and lead strategic research and early development alliances with global biotech, pharma, and academic partners
• Serve as the executive relationship lead across joint governance committees and partnership structures
• Drive alignment on scientific strategy, deliverables, milestones, and investment decisions
• Lead cross-functional program teams across discovery, translational scien...